🔗 Permalink

Inventor profile of:

Erik Depla

City:

Destelbergen

Country:

Belgium

Published Applications:

57

Last publication date:

2024-08-22

Top Assignees for applications by Erik Depla

The entities that hold a legal rights for patent applications filed by inventor Depla Erik:

Ablynx N.V. 16 Zwijnaarde, Belgium
Ablynx N.V. 12 Ghent-Zwijnaarde, Belgium
Innogenetics N.V. 11 Ghent, Belgium
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 10 Ingelheim am Rhein, Germany
Vectura GMBH 2 Gauting, Germany
GENIMMUNE 1 Ghent, Belgium
VIB VZW 1 Ghent, Belgium
Epimmune Inc. 1 San Diego, CA United States
Pharmexa Inc. 1 San Diego, CA United States
INNOGENTICS N.V. 1 Ghent, Belgium
N.V. INNOGENETICS S.A. 1 Ghent, Belgium

Recent patent applications by Depla Erik

Erik Depla from Destelbergen, BE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-08-22

US20240279349A2

Chemistry; metallurgy

CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

#2 | 2024-01-25

US20240026013A2

Chemistry; metallurgy

CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

#3 | 2023-06-29

US20230203146A1

Chemistry; metallurgy

ANG2-BINDING MOLECULES

#4 | 2023-02-16

US20230046772A1

Chemistry; metallurgy

Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

#5 | 2022-01-20

US20220017642A1

Chemistry; metallurgy

Bispecific binding molecules binding to VEGF and Ang2

#6 | 2021-11-11

US20210346287A1

Human necessities

Methods and compositions for the preparation of aerosols

#7 | 2020-08-13

US20200255504A1

Chemistry; metallurgy

Serum albumin binding agents

#8 | 2020-07-02

US20200207845A1

Chemistry; metallurgy

ANG2-BINDING MOLECULES

#9 | 2020-04-23

US20200123233A1

Chemistry; metallurgy

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

#10 | 2020-01-09

US20200010569A1

Chemistry; metallurgy

Bispecific binding molecules binding to VEGF and Ang2

#11 | 2019-10-24

US20190322753A1

Chemistry; metallurgy

CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

#12 | 2019-05-09

US20190135907A1

Chemistry; metallurgy

ANG2-BINDING MOLECULES

#13 | 2019-05-02

US20190127447A1

Chemistry; metallurgy

TREATMENT OF RSV INFECTION

#14 | 2019-03-14

US20190077847A1

Chemistry; metallurgy

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

#15 | 2018-04-19

US20180105581A1

Chemistry; metallurgy

Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

#16 | 2018-02-01

US20180030141A1

Chemistry; metallurgy

CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

#17 | 2017-11-23

US20170333344A1

Human necessities

Methods and compositions for the preparation of aerosols

#18 | 2017-10-26

US20170304566A1

Human necessities

Methods of treating RSV infections

#19 | 2017-10-26

US20170304565A1

Human necessities

Inhalation device for use in aerosol therapy of respiratory diseases

#20 | 2017-08-31

US20170247475A1

Chemistry; metallurgy

Bispecific binding molecules binding to VEGF and Ang2

#21 | 2017-05-18

US20170137512A1

Chemistry; metallurgy

KV1.3 binding immunoglobulins

#22 | 2017-04-20

US20170107281A1

Chemistry; metallurgy

ANG2-BINDING MOLECULES

#23 | 2016-12-08

US20160355595A1

Chemistry; metallurgy

CX3CR1-binding polypeptides

#24 | 2016-09-29

US20160280799A1

Chemistry; metallurgy

Pulmonary administration of immunoglobulin single variable domains and constructs thereof

#25 | 2016-06-02

US20160152693A1

Chemistry; metallurgy

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

#26 | 2015-08-27

US20150239971A1

Chemistry; metallurgy

Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides

#27 | 2015-04-30

US20150118233A1

Chemistry; metallurgy

Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

#28 | 2013-10-03

US20130259859A1

Chemistry; metallurgy

ANG2-BINDING MOLECULES

#29 | 2013-08-29

US20130224224A1

Chemistry; metallurgy

CX3CR1-binding polypeptides comprising immunoglobulin single variable domains

#30 | 2013-05-30

US20130136744A1

Human necessities

Pulmonary administration of immunoglobulin single variable domains and constructs thereof

#31 | 2013-03-28

US20130078248A1

Chemistry; metallurgy

Bispecific binding molecules binding to VEGF and ANG2

#32 | 2013-03-28

US20130078247A1

Chemistry; metallurgy

BISPECIFIC BINDING MOLECULES BINDING TO DII4 AND ANG2

#33 | 2013-01-24

US20130019860A1

Human necessities

Methods and compositions for the preparation of aerosols

#34 | 2012-11-29

US20120301469A1

Chemistry; metallurgy

Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections

#35 | 2012-05-24

US20120128669A1

Chemistry; metallurgy

Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

#36 | 2011-12-22

US20110311515A1

Chemistry; metallurgy

PULMONARY ADMINISTRATION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND CONSTRUCTS THEREOF

#37 | 2011-07-28

US20110182897A1

Chemistry; metallurgy

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

#38 | 2011-06-02

US20110129489A1

Human necessities

METHODS FOR GENERATING AN IMMUNE RESPONSE USING DNA AND A VIRAL VECTOR

#39 | 2011-05-12

US20110110974A1

Human necessities

METHODS AND KITS FOR INDUCING A CTL RESPONSE USING A PRIME BOOST REGIMEN

#40 | 2010-04-22

US20100099613A1

Chemistry; metallurgy

PEPTIDES FOR INDUCING A CTL AND/OR HTL RESPONSE TO HEPATITIS C VIRUS

#41 | 2009-12-17

US20090311248A1

Chemistry; metallurgy

Hepatitis C Virus Neutralizing Antibodies

#42 | 2009-04-23

US20090104207A1

Chemistry; metallurgy

Hepatitis C Virus Neutralizing Antibodies

#43 | 2008-11-06

US20080274144A1

Chemistry; metallurgy

HCV E1 COMPRISING SPECIFIC DISULFIDE BRIDGES

#44 | 2008-05-29

US20080124763A1

Chemistry; metallurgy

Constructs and methods for expression of recombinant proteins in methylotrophic yeast cells

#45 | 2008-01-01

US10128587

Constructs and methods for expression of recombinant HCV envelope proteins

#46 | 2007-07-03

US10128590

Core-glycosylated HCV envelope proteins

#47 | 2007-03-01

US20070048281A1

Chemistry; metallurgy

HCV COMBINATION THERAPY

#48 | 2006-12-07

US20060275323A1

Chemistry; metallurgy

Particles of HCV envelope proteins: use for vaccination

#49 | 2006-09-19

US9995860

Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use

#50 | 2006-05-23

US10128578

Expression of core-glycosylated HCV envelope proteins in yeast

#51 | 2006-05-04

US20060093617A1

Chemistry; metallurgy

Peptides for inducing a CTL and/or HTL response to hepatitis C virus

#52 | 2006-04-13

US20060078932A1

Chemistry; metallurgy

Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes

#53 | 2006-02-16

US20060034861A1

Chemistry; metallurgy

HCV E1 comprising specific disulfide bridges

#54 | 2005-03-10

US20050053617A1

Chemistry; metallurgy

Modified HCV NS3

#55 | 2005-02-17

US20050037018A1

Chemistry; metallurgy

HCV combination therapy

#56 | 2005-01-20

US20050014136A1

Chemistry; metallurgy

Modified HCV NS5

#57 | 2005-01-11

US10318200

Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue

InventorID:

46643 ⎘